Skip to main content
Log in

Impact of sub-gastrectomy on glucose regulation in gastric cancer patients with T2DM: a follow-up study

  • Original Article
  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

Abstract

This study aims to investigate the changing characteristics of glucose regulation after gastric surgery for normal gastric cancer patients with type 2 diabetes mellitus (T2DM) (T2DM group) and without T2DM (normal group) in a tertiary hospital located in western China. We conducted a case-control study which retrospectively collected the data of 73 patients: (1) diagnosed as gastric cancer, (2) underwent sub-gastrectomy and Billroth II gastrointestinal anastomosis between October 2007 and December 2012, and (3) did not suffer a recurrent cancer and with sufficient clinical data. Fasting blood glucose (FBG), glycated hemoglobin (HbA1c), insulin sensitive index (HOMA-IS), insulin resistance index (HOMA-IR), and beta cell function index (HOMA-BCF) were compared at baseline and postoperative 7, 14, 28, 56, 120, and 356 days. Baseline FBG, HbA1c, HOMA-IS, HOMA-IR, and HOMA-BCF in the T2DM group were significantly higher than those in the normal group. Immediate postoperative glucose changed significantly, and it became stable and normal during follow-up period in both the T2DM and normal group that there was no significance anymore after postoperative 28 days between them. Normal patients with T2DM would benefit from gastric surgery in glucose control, and it may involve not only decreased food intake and weight loss but also gastrointestinal reconstruction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Adeghate E, Schattner P, Dunn E. An update on the etiology and epidemiology of diabetes mellitus. Ann N Y Acad Sci. 2006;1084:1–29.

    Article  PubMed  Google Scholar 

  2. Zuo H, Shi Z, Hussain A. Prevalence, trends and risk factors for the diabetes epidemic in china: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2014;104(1):63–72.

    Article  PubMed  Google Scholar 

  3. Du T, Sun X, Huo R, et al. Visceral adiposity index, hypertriglyceridemic waist and risk of diabetes: the china health and nutrition survey 2009. Int J Obes. 2014;38(6):840–7.

    Article  CAS  Google Scholar 

  4. Tseng CH. Diabetes conveys a higher risk of gastric cancer mortality despite an age-standardised decreasing trend in the general population in Taiwan. Gut. 2011;60:774e779.

    Article  Google Scholar 

  5. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38(1):140–9.

    Article  PubMed  Google Scholar 

  6. Musella M, Milone M, Bellini M, Sosa Fernandez L, Leongito M, et al. Effect of bariatric surgery on obesity-related infertility. Surg Obes Relat Dis. 2012;8:445–9.

    Article  PubMed  Google Scholar 

  7. Klein S, Ghosh A, Cremieux PY, et al. Economic impact of the clinical benefits of bariatric surgery in diabetes patients with BMI≥ 35 kg/m2. Obesity. 2011;19(3):581–7.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Lifshitz F, Hall J. Reduction in the incidence of type II diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.

    Article  Google Scholar 

  9. Heymsfield S, Segal K, Hauptman J, Lucas C, Boldrin M, et al. Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults. Arch Intern Med. 2000;160:1321–6.

    Article  CAS  PubMed  Google Scholar 

  10. Picot J, Jones J, Colquitt J, Gospodarevskaya E, Loveman E, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13:1–190.

    Article  CAS  Google Scholar 

  11. Zhu Z, Shan X, Cheng Y, et al. Clinical course of diabetes after gastrectomy according to type of reconstruction in patients with concurrent gastric cancer and type 2 diabetes. Obes Surg. 2015;25(4):673–9.

    Article  PubMed  Google Scholar 

  12. Liu T, Xie G, Tian Q, et al (2015) Radical gastrectomy combined with modified gastric bypass surgery for gastric cancer patients with type 2 diabetes. Cell Biochem Biophys: 1–6

  13. Zimmet P, Shaw J, Alberti K. Preventing type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view. Diabet Med. 2003;20:693–702.

    Article  CAS  PubMed  Google Scholar 

  14. Emoto M, Nishizawa Y, Maekawa K, Hiura Y, Kanda H, et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care. 1999;22:818–22.

    Article  CAS  PubMed  Google Scholar 

  15. Levy J, Matthews D, Hermans M. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21:2191–2.

    Article  CAS  PubMed  Google Scholar 

  16. O’Brien PE, McPhail T, Chaston TB, Dixon JB. Systematic review of medium-term weight loss after bariatric operations. Obes Surg. 2006;16:1032–40.

    Article  PubMed  Google Scholar 

  17. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, et al. Effect of laparoscopic roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238:467.

    PubMed  PubMed Central  Google Scholar 

  18. Li Q, Chen L, Yang Z, Huang Y, He M, et al. Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index < 35 kg/m2. Diabetes Obes Metab. 2012;14:262–70.

    Article  CAS  PubMed  Google Scholar 

  19. Shimizu H, Timratana P, Schauer P, Rogula T. Review of metabolic surgery for type 2 diabetes in patients with a BMI <35 Kg/M 2. J Obes. 2012;2012:147256.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Dixon J, le Roux C, Rubino F, Zimmet P. Bariatric surgery for type 2 diabetes. Lancet. 2012;379:2300–11.

    Article  PubMed  Google Scholar 

  21. Mingrone S, Panunzi A, Mingrone G, Panunzi S, de Gaetano A, Guidone C, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577–85.

    Article  CAS  PubMed  Google Scholar 

  22. Camastra S, Manco M, Mari A, Greco A, Frascerra S, et al. β-cell function in severely obese type 2 diabetic patients long-term effects of bariatric surgery. Diabetes Care. 2007;30:1002–4.

    Article  CAS  PubMed  Google Scholar 

  23. Rao RS, Kini S. GIP and bariatric surgery. Obes Surg. 2011;21:244–52.

    Article  PubMed  Google Scholar 

  24. Rubino F, Schauer P, Kaplan L, Cummings D. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med. 2010;61:393–411.

    Article  CAS  PubMed  Google Scholar 

  25. Buchwald H, Avidor Y, Braunwald E, Jensen M, Pories W, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.

    Article  CAS  PubMed  Google Scholar 

  26. Ali M, Bullard K, Saaddine J, Cowie C, Imperatore G, et al. Achievement of goals in US diabetes care, 1999–2010. N Engl J Med. 2013;368:1613–24.

    Article  CAS  PubMed  Google Scholar 

  27. Bakris G. Clinical guidelines: blood pressure goals in T2DM: a Latin American perspective. Nat Rev Endocrinol. 2013;9:138–9.

    Article  PubMed  Google Scholar 

  28. Massi-Benedetti M. Changing targets in the treatment of type 2 diabetes. Curr Med Res Opin. 2006;22:S5–S13.

    Article  CAS  PubMed  Google Scholar 

  29. Guo X, Liu X, Wang M, Wei F, Zhang Y, et al. The effects of bariatric procedures versus medical therapy for obese patients with type 2 diabetes: meta-analysis of randomized controlled trials. BioMed Res Int. 2013;2013:410609.

    PubMed  PubMed Central  Google Scholar 

Download references

Compliance with ethical standards

Funding

This study was funded by Gansu Provincial Health Department of Research Projects (grant number WST07-07).

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Authors’ contributions

Zhang YC, Wang HL, Zhang YW, and Xu XD were involved in the study conception and design. Wei FX, Han W, and Zhang HH participated in the acquisition of data. Wei ZG, Zhang YW, Wang MC, and Xu XD were involved in the analysis and interpretation of data. Wei FX and Han W participated in the drafting of manuscript. Zhang YC and Wang HL were involved in the critical revision of manuscript.

Conflict of interest

You Cheng Zhang, Feng Xian Wei, Wei Han, Hui Lin Wang, Man Cai Wang, Ya Wu Zhang, Xiao Dong Xu, and Hui Han Zhang declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to You Cheng Zhang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, Y.C., Wei, F.X., Han, W. et al. Impact of sub-gastrectomy on glucose regulation in gastric cancer patients with T2DM: a follow-up study. Int J Diabetes Dev Ctries 36, 89–94 (2016). https://doi.org/10.1007/s13410-015-0437-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13410-015-0437-6

Keywords

Navigation